86 related articles for article (PubMed ID: 11115545)
1. K-ras mutation in sputum of primary lung cancer patients does not always reflect that of cancerous cells.
Nakajima E; Hirano T; Konaka C; Ikeda N; Kawate N; Ebihara Y; Kato H
Int J Oncol; 2001 Jan; 18(1):105-10. PubMed ID: 11115545
[TBL] [Abstract][Full Text] [Related]
2. [Detection of K-ras mutation from malignant cells in sputum with mutant-allele specific amplification (MASA) method].
Kimura S; Fukuchi K; Takeda S; Shin S; Saito D; Akamatsu S; Himeji Y; Chen GL; Watanabe H; Takagi Y
Rinsho Byori; 1995 Jul; 43(7):718-23. PubMed ID: 7674546
[TBL] [Abstract][Full Text] [Related]
3. K-ras mutation in sputum of patients with or without lung cancer.
Ronai Z; Yabubovskaya MS; Zhang E; Belitsky GA
J Cell Biochem Suppl; 1996; 25():172-6. PubMed ID: 9027615
[TBL] [Abstract][Full Text] [Related]
4. [Detection of oncogenic mutations in sputum and its diagnostic value of lung cancer].
Wang L; Wang G; Xia X
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Apr; 21(4):236-9. PubMed ID: 11326973
[TBL] [Abstract][Full Text] [Related]
5. Low mutational rate of K-ras codon 12 in singular bronchoscopy specimens in suspected lung cancer.
Spasova I; Novotna H; Vachtenheim J; Bartosova H; Patek J; Hoserova V; Zatloukal P; Kinkor Z
Neoplasma; 2005; 52(3):255-9. PubMed ID: 15875089
[TBL] [Abstract][Full Text] [Related]
6. Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA).
Takeda S; Ichii S; Nakamura Y
Hum Mutat; 1993; 2(2):112-7. PubMed ID: 8318987
[TBL] [Abstract][Full Text] [Related]
7. Detection of K-ras mutations of bronchoalveolar lavage fluid cells aids the diagnosis of lung cancer in small pulmonary lesions.
Oshita F; Nomura I; Yamada K; Kato Y; Tanaka G; Noda K
Clin Cancer Res; 1999 Mar; 5(3):617-20. PubMed ID: 10100714
[TBL] [Abstract][Full Text] [Related]
8. Detection of activated K-ras in non-small cell lung cancer by membrane array: a comparison with direct sequencing.
Chong IW; Chang MY; Sheu CC; Wang CY; Hwang JJ; Huang MS; Lin SR
Oncol Rep; 2007 Jul; 18(1):17-24. PubMed ID: 17549340
[TBL] [Abstract][Full Text] [Related]
9. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
[TBL] [Abstract][Full Text] [Related]
10. Second primary cancers after resection of lung adenocarcinoma with ras gene mutation.
Sugio K; Fukuyama Y; Sakada T; Nishioka K; Yamazaki K; Ushijima C; Tsukamoto S; Ishida T; Sugimachi K
Anticancer Res; 1998; 18(5A):3395-8. PubMed ID: 9858914
[TBL] [Abstract][Full Text] [Related]
11. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
[TBL] [Abstract][Full Text] [Related]
12. K-ras and p16(INK4A)alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers.
Destro A; Bianchi P; Alloisio M; Laghi L; Di Gioia S; Malesci A; Cariboni U; Gribaudi G; Bulfamante G; Marchetti A; Bosari S; Infante M; Ravasi G; Roncalli M
Lung Cancer; 2004 Apr; 44(1):23-32. PubMed ID: 15013580
[TBL] [Abstract][Full Text] [Related]
13. Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer.
Kim DH; Kim JS; Park JH; Lee SK; Ji YI; Kwon YM; Shim YM; Han J; Park J
Cancer Res; 2003 Oct; 63(19):6206-11. PubMed ID: 14559805
[TBL] [Abstract][Full Text] [Related]
14. Detection of p53 and K-ras mutations in sputum of individuals exposed to smoky coal emissions in Xuan Wei County, China.
Keohavong P; Lan Q; Gao WM; Zheng KC; Mady HH; Melhem MF; Mumford JL
Carcinogenesis; 2005 Feb; 26(2):303-8. PubMed ID: 15564291
[TBL] [Abstract][Full Text] [Related]
15. Mixed mucinous-type and non-mucinous-type adenocarcinoma of the lung: immunohistochemical examination and K- ras gene mutation.
Maeshima A; Sakamoto M; Hirohashi S
Virchows Arch; 2002 Jun; 440(6):598-603. PubMed ID: 12070599
[TBL] [Abstract][Full Text] [Related]
16. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer.
Mao L; Hruban RH; Boyle JO; Tockman M; Sidransky D
Cancer Res; 1994 Apr; 54(7):1634-7. PubMed ID: 8137272
[TBL] [Abstract][Full Text] [Related]
17. Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?
Camps C; Sirera R; Bremnes R; Blasco A; Sancho E; Bayo P; Safont MJ; Sánchez JJ; Tarón M; Rosell R
Lung Cancer; 2005 Dec; 50(3):339-46. PubMed ID: 16139926
[TBL] [Abstract][Full Text] [Related]
18. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program.
Baryshnikova E; Destro A; Infante MV; Cavuto S; Cariboni U; Alloisio M; Ceresoli GL; Lutman R; Brambilla G; Chiesa G; Ravasi G; Roncalli M
Clin Cancer Res; 2008 Mar; 14(6):1913-9. PubMed ID: 18347195
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of ras gene family in lung cancer in Thai.
Petmitr S; Wongsommart D; Chaksangchaichot P; Pakeetoot T; Sutinont P; Sirivaidyapong P; Karalak A
Oncol Rep; 2003; 10(5):1497-501. PubMed ID: 12883730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
